LogoLLF


Media
I Contact Us  I Links

      INSIDE LLF  I  OUR PEOPLE  I  PRACTICE AREAS  I  CAREERS
News & Events


Yaz birth control pill is linked with risk of blood clots, heart attack, stroke and gallbladder disease

The Yaz birth control pill has been linked with serious adverse heart problems. The FDA sent a letter to the manufacturer of Yaz that reiterates the risk of blood clots, heart attack, stroke and gallbladder disease in Yaz users. The FDA also states that Yaz has additional risks because it contains the progestin, drospirenone that can lead to hyperkalemia in high risk patients, which may result in potentially serious heart and health problems. Women taking Yaz must be on heightened alert about drug interactions that can increase potassium, in addition to drug interactions common to all combination oral contraceptives. These adverse reactions can included fatal arrhythmias which results from abnormal potassium levels. Yaz and other oral contraceptives have an increased risk of heart attack, and there is a link between oral contraceptives and blood clots and stroke. In January 2009, the FDA reprimanded the manufacturer of Yaz for marketing it to treat headaches and acne, which are uses that are not approved by the FDA. If you or a family member took Yaz and suffered a blood clot, stroke or heart attack, we urge you to contact our office to obtain additional information about recovering financial compensation for your injuries.

 

 

 




  DC/NJ/NY/PA
  © 2009 LLF All rights reserved.   
Home I Contact Us